Theoretically, monoclonal antibodies hold huge potential for safe and highly effective new global health products. Our investment attempted to turn theory into product within this emerging class of drugs.
Featured Stories
When a mobile payments platform in Bangladesh achieved product-market-fit, our investment helped it scale in low income, rural areas.
To improve access to family planning, the Gates Foundation strategic investing team sought to increase the availability and affordability of contraceptive implants.
Article
Tackling diarrheal disease
Cholera, a preventable but devastating illness, causes thousands of avoidable deaths each year in the world’s poorest communities. Our strategic investments helped lower the cost of an oral cholera vaccine.
Resources
Promoting Gender Equity in Companies: A Closer Look
A resource guide for early and growth stage companies
A Smart Strategy
Why gender equity strengthens companies from their earliest stages, and how to make sure you’re getting it right.